Takeda

Executive Summary

Takeda is a major Japanese multinational pharmaceutical company with dual headquarters in Tokyo and Cambridge, making it one of the largest pharma companies globally. The company has a strong deal-making posture with significant M&A activity and licensing partnerships, particularly in oncology, gastroenterology, and rare diseases. As a Japanese company with clear BIOSECURE status, Takeda presents minimal regulatory risk for US partnerships. However, the lack of available data on key personnel and recent activities suggests limited transparency or outdated intelligence.

Structure: Takeda operates as a traditional Japanese multinational corporation with a straightforward corporate structure, avoiding the complex VIE arrangements common among Chinese companies. The dual headquarters structure reflects their global operations and significant Western presence following major acquisitions including Shire in 2019.